Integra LifeSciences Holdings Corporation (IART)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Integra LifeSciences Holdings Corporation (IART) is up 41.7% since the beginning of the year. At $18 per share, IART is trading 3.8% below its 52-week high of $18. Investors who bought $1,000 worth of IART shares 5 years ago would now be looking at an investment worth $248.

Integra LifeSciences Holdings Corporation (IART) has returned 41.71% so far this year and 51.72% over the past 12 months. Over the last ten years, IART has returned -7.42% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Aug 16, 1995, IART's average daily return is +0.07%, while the average monthly return is +1.17%. At this rate, an investment would double in approximately 5.0 years.

Historically, 53% of months were positive and 47% were negative. The best month was Feb 2000 with a return of +99.1%, while the worst month was Jul 1996 at -48.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, IART closed higher 50% of trading days. The best single day was Mar 10, 1997 with a return of +41.7%, while the worst single day was Aug 16, 1995 at -40.4%.

Integra LifeSciences Holdings Corporation has an annualized alpha of 10.32%, beta of 0.73, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 16, 1995.

• This stock participated in 110.68% of S&P 500 Index downside but only 87.08% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

IART ranks 66 for risk / return — better than 66% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

Integra LifeSciences Holdings Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Integra LifeSciences Holdings Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Integra LifeSciences Holdings Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Integra LifeSciences Holdings Corporation was 88.39%, occurring on Mar 18, 2026. The portfolio has not yet recovered.

The current Integra LifeSciences Holdings Corporation drawdown is 77.03%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Integra LifeSciences Holdings Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Integra LifeSciences Holdings Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.